WEREWOLF THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Increase (Decrease) in Other Noncurrent Assets of -$329.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2024-08-08
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-09-30 was -$136.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-06-30 was -$18.00K, a 101.49% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-03-31 was $18.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-12-31 was -$1.48M, a 328.51% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$279.00K, a 142.99% decline from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $649.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$329.00K 10-Q · filed 2024-08-08 | |||
| 2023-09-30 | -$136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$154.00K derived: sum of 2 quarters · filed 2024-08-08 | -$136.00K 10-Q · filed 2023-11-14 | -$1.62M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$1.48M derived: sum of 3 quarters · filed 2024-08-08 | -$1.49M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $18.00K 10-Q · filed 2023-05-11 | -$1.47M derived: sum of 2 quarters · filed 2023-05-11 | -$1.47M derived: sum of 3 quarters · filed 2023-11-14 | -$261.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$1.49M derived: sum of 2 quarters · filed 2023-11-14 | -$279.00K derived: sum of 3 quarters · filed 2023-11-14 | -$279.00K 10-K · filed 2023-03-23 |
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.20M derived: sum of 2 quarters · filed 2023-11-14 | $1.20M 10-Q · filed 2023-11-14 | $1.85M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.21M 10-Q · filed 2023-08-10 | $1.85M derived: sum of 3 quarters · filed 2023-08-10 | $1.85M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $649.00K derived: sum of 2 quarters · filed 2023-05-11 | $649.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $649.00K derived: sum of 2 quarters · filed 2023-03-23 | $649.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |